Differences in Lower Urinary Tract Symptoms, Treatment and Mortality among African-American and White Elderly Men

The Institute for Health, Social, and Community Research, Raleigh, NC 27601, USA.
Journal of the National Medical Association (Impact Factor: 0.96). 10/2008; 100(10):1146-52. DOI: 10.1016/S0027-9684(15)31480-2
Source: PubMed


There are limited population-based studies of benign prostate hyperplasia (BPH) and lower urinary tract symptoms (LUTS) in men, and most studies examined to date have been restricted to predominately white populations. This study examines treatment and all-cause mortality among a cohort of African-American and white men aged > or =65 with BPH/LUTS symptoms over time.
Data were collected from the Piedmont Health Survey of the Elderly-Established Populations for the Epidemiological Study of the Elderly for 5 North Carolina counties from 1994 (N=502) to 1998 (N=322).
From 1994-1998, there were no significant racial differences in treatment by catheter insertion, prostate surgery or drug therapy for BPH/LUTS. However, overall use of the 3 treatments increased from 1994-1998, with drug therapy showing the largest increase. Adjusted analyses revealed racial differences in prostate surgery only, with African-American men nearly 40% more likely to receive prostate surgery than white men. Men with comorbid conditions were less likely to receive drug therapy, whereas those with poor self-reported health or cancer were more likely to receive prostate surgery. Catheter insertion was more likely for those who had resided in a nursing home. Men who received drug therapy treatment or had regular rectal exams showed decreased risk of mortality.
Findings suggest that healthcare providers should direct more attention to the management of LUTS in white and African-American elderly men. Data also demon-strate the need for studies that focus on treatment modalities as well as important correlates of LUTS.

Download full-text


Available from: Daniel L Howard, Apr 28, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the relationships between the 2nd to 4th digit ratio (digit ratio) and prostate volume, prostate-specific antigen (PSA) level, and the presence of prostate cancer. Of the men that presented with lower urinary tract symptoms (LUTS) at a single tertiary academic center, 366 men aged 40 or older with a PSA level ≤ 40 ng/mL were prospectively enrolled. Right-hand 2nd and 4th digit lengths were measured prior to the PSA determinations and transrectal ultrasonography (TRUS). Prostate volumes were measured by TRUS without information about digit length. Patients with a PSA level ≥ 3 ng/mL underwent prostate biopsy. No relationship was found between prostate volume and digit ratio [correlation coefficient (r) = -0.038, P = 0.466]. But, significant negative correlations were found between digit ratio and PSA (r = -0.140, P = 0.007). When the patients were divided into two groups (Group A: digit ratio < 0.95, n = 184; Group B: digit ratio ≥ 0.95, n = 182), Group A had a higher mean PSA level than Group B (3.26 ± 5.54 ng/mL vs 1.89 ± 2.24 ng/mL, P = 0.002) and had significantly higher risks of prostate biopsy [odds ratio (OR) = 1.75, 95% CI = 1.07-2.84] and prostate cancer (OR = 3.22, 95% CI = 1.33-7.78). Patients with a lower digit ratio have higher risks of prostate biopsy and prostate cancer.
    No preview · Article · Feb 2011 · BJU International
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: • To compare prostate cancer, prostate-related surgery and acute urinary retention rates, as well as associated healthcare resource use over 11 years in African American and Caucasian men with benign prostatic hyperplasia (BPH). • The BPH-related medical and surgical charges and events were determined for 398 African American men and 1656 Caucasian men followed for a mean of 10.2 years within a health maintenance organization. • Racial differences in clinical outcomes were evaluated using time-to-event analysis, stratifying results by baseline prostate-specific antigen (PSA) values. • Risk of a prostate cancer diagnosis was 2.2 times greater in African American than Caucasian men (95% CI 1.48-3.35, P < 0.001) in analyses adjusting for serum PSA level. • Although African Americans were more likely to receive medical therapy for symptoms of BPH than Caucasians (43.5% vs 37.2%, respectively; P= 0.029), there were no clinically meaningful differences with respect to subsequent acute urinary retention or BPH-related surgery between them, or BPH-related medical charges (US $407 vs US $405 per month). • As evidenced by this analysis of 'real-world' clinical practice, African Americans with BPH have a much greater risk of developing prostate cancer than similar Caucasian men highlighting the need for education and early detection in this population.
    Preview · Article · Mar 2011 · BJU International
  • [Show abstract] [Hide abstract]
    ABSTRACT: We examined whether there are racial/ethnic disparities in lower urinary tract symptoms in men. Racial/ethnic disparities were examined using the American Urological Association symptom index in 2 large cohorts, including the California Men's Health Study and the Research Program in Genes, Environment and Health. Prevalence and incidence were calculated in each age and race/ethnicity strata. Multivariate analysis was done to assess the association between race/ethnicity and lower urinary tract symptoms. The lower urinary tract symptom prevalence increased with age in each racial/ethnic category (p <0.05). The mean ± SD age adjusted American Urological Association symptom index score for black, Hispanic, other/mixed, non-Hispanic white and Asian men was 9.57 ± 5.83, 9.35 ± 6.30, 9.32 ± 6.22, 8.99 ± 5.89 and 8.41 ± 5.59, respectively. In multivariate models Hispanic and black men were at increased risk for moderate lower urinary tract symptoms than white men while only Hispanic men were at higher risk for severe lower urinary tract symptoms. Asian men were at lower risk for moderate or severe lower urinary tract symptoms than white men. The incident rate of lower urinary tract symptoms increased with increasing baseline age for almost all racial/ethnic groups (range 32% to 56%). Asian and Hispanic men were at lower risk for incident lower urinary tract symptoms than white men even after adjusting for sociodemographic factors, health related behaviors and comorbidity. Racial/ethnic disparities in lower urinary tract symptoms persist after accounting for putative and established risk factors.
    No preview · Article · Nov 2011 · The Journal of urology
Show more